H.C. Wainwright Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| Boston Dtox, Inc. (NASDAQ: BDTX) | Delayed: 1.77 -0.06 (3.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.83 | 52 Week High | $0.01 | |||
| Open | $1.87 | 52 Week Low | $0.01 | |||
| Day High | $1.87 | P/E | N/A | |||
| Day Low | $1.77 | EPS | $0.00 | |||
| Volume | 377,692 | |||||
